Genome-scale metabolic modeling reveals metabolic alterations of multidrug-resistant Acinetobacter baumannii in a murine bloodstream infection model
Publication Year 2020-11-16,Volume 8,Issue #11,Page 1793
Journal Title
Publication Type
Journal Article
Multidrug-resistant (MDR) Acinetobacter baumannii is a critical threat to human health globally. We constructed a genome-scale metabolic model iAB5075 for the hypervirulent, MDR A. baumannii strain AB5075. Predictions of nutrient utilization and gene essentiality were validated using Biolog assay and a transposon mutant library. In vivo transcriptomics data were integrated with iAB5075 to elucidate bacterial metabolic responses to the host environment. iAB5075 contains 1530 metabolites, 2229 reactions, and 1015 genes, and demonstrated high accuracies in predicting nutrient utilization and gene essentiality. At 4 h post-infection, a total of 146 metabolic fluxes were increased and 52 were decreased compared to 2 h post-infection; these included enhanced fluxes through peptidoglycan and lipopolysaccharide biosynthesis, tricarboxylic cycle, gluconeogenesis, nucleotide and fatty acid biosynthesis, and altered fluxes in amino acid metabolism. These flux changes indicate that the induced central metabolism, energy production, and cell membrane biogenesis played key roles in establishing and enhancing A. baumannii bloodstream infection. This study is the first to employ genome-scale metabolic modeling to investigate A. baumannii infection in vivo. Our findings provide important mechanistic insights into the adaption of A. baumannii to the host environment and thus will contribute to the development of new therapeutic agents against this problematic pathogen.
WEHI Research Division(s)
Population Health And Immunity
PubMed ID
Terms of Use/Rights Notice
Refer to copyright notice on published article.

Creation Date: 2021-02-01 12:08:27
Last Modified: 2021-03-02 03:09:57
An error has occurred. This application may no longer respond until reloaded. Reload 🗙